Finance

Lists
ZYDUSLIFE:NSE
Zydus Lifesciences Ltd
₹ १,१२३.००
-१.५१%
(-१७.२०) 1D
अक्टोबर १६, १५:३०:०० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ZYDUSLIFE...
Open
₹ १,१४०.१०
High
₹ १,१४६.५०
Low
₹ १,१२३.००
Mkt. cap
११.२० खरब
Avg. vol.
१४.१७ लाख
Volume
१५.९९ लाख
Dividend
०.०९%
Quarterly dividend
₹ ०.२५
Ex-dividend date
२०२६ जुलाई २४
P/E ratio
२५.०३
52-wk high
₹ १,२३२.१०
52-wk low
₹ ८३५.५०
EPS
₹ ४४.८७
No. of employees
३० हजार
Open
₹ १,१४०.१०
High
₹ १,१४६.५०
Low
₹ १,१२३.००
Mkt. cap
११.२० खरब
Avg. vol.
१४.१७ लाख
Volume
१५.९९ लाख
Dividend
०.०९%
Quarterly dividend
₹ ०.२५
Ex-dividend date
२०२६ जुलाई २४
P/E ratio
२५.०३
52-wk high
₹ १,२३२.१०
52-wk low
₹ ८३५.५०
EPS
₹ ४४.८७
No. of employees
३० हजार
News stories
From web sources and news partners
The Fintech Times
The Fintech Times
·
३२ मिनेट पहिले
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Yahoo Finance
Yahoo Finance
·
१ घण्टा पहिले
Anthropic IPO Buzz Has Investors Watching Nasdaq Stock And ECM Fee Winners
Bloomberg.com
Bloomberg.com
·
४ घण्टा पहिले
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad. Primarily engaged in the manufacturing of generic drugs, the company ranked 100th in the Fortune India 500 list in 2020. Wikipedia
About Zydus Lifesciences Ltd
CEO-
Employees३० हजार
Founded१९५२
Headquarters-
Sector-
Last report
२०२६ अगस्ट ११
Fiscal period
Q1 2027
₹ ९.४८ / ₹ ११.१५
-१४.९८%miss
Revenue / Est. (INR)
८०.१७ अरब / ७६.८७ अरब
+४.३०%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
६१.२३ अरब
६८.६४ अरब
७५.८७ अरब
८०.१७ अरब
Cost of goods sold
१६.९० अरब
१८.३६ अरब
२२.०७ अरब
२२.४० अरब
Cost of revenue
१६.९० अरब
१८.३६ अरब
२२.०७ अरब
२२.४० अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१०.३४ अरब
११.४० अरब
३२.९२ अरब
१३.६८ अरब
Operating expense
३१.३३ अरब
३७.३६ अरब
३९.४० अरब
४४.५९ अरब
Total operating expenses
४८.२३ अरब
५५.७२ अरब
६१.४८ अरब
६६.९९ अरब
Operating income
१३.०० अरब
१२.९२ अरब
१४.३९ अरब
१३.१८ अरब
Other non operating income
१.०९ अरब
१.११ अरब
-३.७० अरब
१.०६ अरब
EBT including unusual items
१६.९३ अरब
१४.११ अरब
१६.५९ अरब
१३.४४ अरब
EBT excluding unusual items
१७.२७ अरब
१४.९६ अरब
२०.८८ अरब
१३.६३ अरब
Income tax expense
४.५४ अरब
३.८८ अरब
३.१८ अरब
३.५४ अरब
Effective tax rate
२६.८२%
२७.५२%
१९.१९%
२६.३५%
Other operating expenses
१७.९७ अरब
२२.३६ अरब
१.२८ अरब
२५.३६ अरब
Net income
१२.५९ अरब
१०.४२ अरब
१२.७२ अरब
९.४० अरब
Net profit margin
२०.५५%
१५.१८%
१६.७७%
११.७२%
Earnings per share
१२.७६
१०.९६
१५.८४
९.४८
Interest and investment income
-
-
४.२४ अरब
-
Interest expense
-१.०१ अरब
-१.३० अरब
-४९.१० करोड
-१.५६ अरब
Net interest expenses
-१.०१ अरब
-१.३० अरब
३.७५ अरब
-१.५६ अरब
Depreciation and amortization charges
३.०२ अरब
३.६० अरब
५.०८ अरब
५.५५ अरब
EBITDA
१५.७० अरब
१५.१० अरब
१७.७४ अरब
१६.५३ अरब
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू